Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 11/20 | 0.45 |
| ▸ | LPAR2 | Q9HBW0 | 9/20 | 0.45 |
| ▸ | LPAR1 | Q92633 | 11/20 | 0.41 |
| ▸ | ENPP2 | Q13822 | 4/20 | 0.39 |
| ▸ | LPAR4 | Q99677 | 2/20 | 0.32 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.32 |
| ▸ | CES2 | O00748 | 1/20 | 0.32 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.32 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29067752 | 0.98 | LPAR3 (0.46) | LPAR3LPAR2LPAR1ENPP2LPAR4 | |
| SCHEMBL29067753 | 0.98 | LPAR3 (0.46) | LPAR3LPAR2LPAR1ENPP2LPAR4 | |
| SCHEMBL3264608 | 0.77 | LPAR3 (0.55) | LPAR3LPAR2LPAR1ENPP2 | |
| SCHEMBL4533955 | 0.65 | LPAR3 (0.53) | LPAR3LPAR2LPAR1ENPP2LPAR5 | |
| SCHEMBL4527062 | 0.65 | LPAR3 (0.53) | LPAR3LPAR2LPAR1ENPP2LPAR5 | |
| SCHEMBL4530286 | 0.65 | LPAR3 (0.53) | LPAR3LPAR2LPAR1ENPP2LPAR5 | |
| SCHEMBL4517304 | 0.65 | LPAR3 (0.53) | LPAR3LPAR2LPAR1ENPP2LPAR5 | |
| SCHEMBL4528601 | 0.65 | LPAR3 (0.53) | LPAR3LPAR2LPAR1ENPP2LPAR5 | |
| SCHEMBL4538823 | 0.65 | LPAR3 (0.53) | LPAR3LPAR2LPAR1ENPP2LPAR5 | |
| SCHEMBL4524025 | 0.65 | LPAR3 (0.53) | LPAR3LPAR2LPAR1ENPP2LPAR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116554249-A | Antiviral compounds and uses thereof | 北京恩泰伟医药科技有限公司 | 2023-08-08 | — | — | CN | disclosed |